FDA Investigator Patricia F Hughes, PhD
Patricia F Hughes, PhD has inspections in 2 countries as of 10 Feb 2023. Patricia F Hughes, PhD has collaborated with a combinined 1722 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
5
Last Inspection Date:
10 Feb 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America,
France
Co-Investigator(s):
Amir Alavi,
Amy Devlin, PhD,
Anita Narula, PhD,
Ann L Demarco,
Ashar P Parikh,
Ashutosh Rao, PhD,
Bo Chi, PhD,
Bonita S Chester,
Candace Gomez Broughton, PhD,
Carl Lee,
Carla J Lundi,
Carolyn A Renshaw,
CDR Ileana Barreto Pettit,
CDR Rochelle B Young, RPh, MSA,
Christopher Downey, PhD,
David G Eng,
Dennis E Guilfoyle, PhD,
Devaughn Edwards,
Dr. Robert C Horan, MD,
Gibbes Johnson, PhD,
Henry K Lau,
Jacek Cieslak, PhD,
Jacqueline Mdiaz Albertini,
James R Evans,
Jason F Chancey,
Jee Chung, PhD,
Jeffrey M Watson,
Joan A Loreng,
Joao Pedras Vasconcelos, PhD,,
John A Podsadowski,
John D Finkbohner, PhD,
Joseph Kutze, PhD,
Kathryn E King,
Keith O Webber, PhD,
Keith Webber, PhD,
Kouros Kangarli,
Lance M De Souza, MBA,
Laurie Graham,
Lawrence W Farina,
Leopold Kong, PhD,
Leslie Arivera Rosado, PhD,
Linan Ha, PhD,
Linda M Sacco,
Lucila B Nwatu,
Mariza M Jafary,
Marshalette Edwards,
Marshalette O Edwards,
Mary Kaulee,
Michael Levin,
Michelle Rfrazier Jessen, PhD,
Mihaly S Ligmond,
Milos Dokmanovic, PhD,
Natalia Pripuzova, PhD,
Nicholas C Mendiola,
Nicholas L Hunt,
Parul M Patel,
Patricia Fhughes Troost,
Paula A Trost,
Penny H Mccarver,
Peter E Baker,
Qing Joanna Zhou, PhD,
Rashmi Rawat, PhD,
Rebecca Rodriguez,
Reyes Candau Chacon, PhD,
Robert D Tollefsen,
Russ E Davis,
Ruth Moore, PhD,
Sarah Johnson, PhD,
Scott N Lim,
Seneca D Toms,
Sharon K Thoma, PharmD,
Sidney B Priesmeyer,
Simon Williams, PhD,
Sonya M Edmonds,
Stephanie A Slater, MS,
Steven Fong, MS, PhD,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Uttaniti Limchumroon (Tom),
Veronica Fuentes, MS,
Virginia Carroll, PhD,
William M Rennells,
William V Millar,
Xiaoxiao Pan, PhD,
Xuhong Li,
Yuan Chia Kuo,
Yun Wu, PhD,
Zhenzhen Liu, PhD,
Zhihao Qiu (Peter), PhD
Patricia F Hughes, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2022 | EIR | Revance Therapeutics, Inc. - EIR, 2022-07-15 |
February, 2000 | EIR | Genentech, Inc. - EIR, 2000-02-14 |
February, 2023 | FDA 483 | FUJIFILM Diosynth Biotechnologies U.S.A., Inc - Form 483, 2023-02-10 |
February, 2000 | FDA 483 | Genentech, Inc. - Form 483, 2000-02-14 |
June, 2000 | FDA 483 | Sanofi Recherche - Form 483, 2000-06-07 |
July, 2022 | FDA 483 | Revance Therapeutics, Inc. - Form 483, 2022-07-15 |
February, 2013 | EIR | Bristol-Myers Squibb Co., Inc. - EIR, 2013-02-08 |
June, 2000 | EIR | Sanofi Recherche - EIR, 2000-06-07 |
February, 2013 | FDA 483 | Bristol-Myers Squibb Co., Inc. - Form 483, 2013-02-07 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more